Element Biosciences
Precision Medicine & Genomics
Element Biosciences develops innovative genetic analysis tools, empowering the scientific community with freedom and flexibility to accelerate biological discoveries.
About Element Biosciences
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Leadership Team
Key executives and founders sourced from public LinkedIn profiles.
Element Biosciences is a pioneering life science company democratizing access to advanced biological tools, driving impactful discoveries to benefit humanity. We are focused on developing disruptive DNA sequencing and multi-omics technology for research markets. Through innovating every fundamental element of a biological assay system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries. To learn more about Element, please visit www.elementbiosciences.com
I am an Economist by education, a Senior Finance Executive by occupation, a Strategist by instinct, and Optimist by upbringing. These personas are the foundation for my 20+ years of professional experience serving clients as a “Big 4” Accountant and creating accretive financial growth as a Chief Financial Officer. I love the “Aha!” moments – when the solution to a problem becomes crystal clear. My passion, expertise and business acumen consistently drive shareholder value, whether through complex modeling and deal negotiation, or developing future leaders of the organization. But actual experience has taught me that my professional values boil down to the following: • I have an extroverted approach to communication • I am a pragmatic visionary • I am not looking for the limelight; rather I’m looking to win as a team • I am the calm one that runs towards fires • I have fun and take pride in my work
Mission & Approach
Mission
“Our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity.”
AI Approach
Not explicitly mentioned - focus is on sequencing chemistry and multiomics detection rather than AI/ML
Founding Story
Element Biosciences is founded and led by industry veterans who believe that high-quality sequencing doesn't have to come at a high price.
Product & Market
Product Stage
launchedPrimary Market
researchCompany Details
- Founded
- 2017
- Headquarters
- San Diego, CA, USA
- Employees
- 375
- Stage
- growth
- Profile last updated
- June 22, 2026
Category
Precision Medicine & GenomicsOfficial Sources
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSocial & Media
Follow on
X / Twitter
View Profile →Latest Updates
.jpeg)
Strand-seq: A single cell sequencing technology coming into its own
How advances in automation, single cell biology, and next-generation sequencing are finally unlocking the full promise of one of genomics' most powerful, and most underutilized, techniques. The problem with knowing half a genome You carry two copies of every chromosome, one from each parent, and those copies can differ in ways that matter enormously for disease risk and drug response. Assembling both copies end to end, and determining which variant came from which parent, is the true goal of per
May 26, 2026
Read more →.jpeg)
Spatially resolved variant calling in cancer tissue
Direct In Sample Sequencing on AVITI24™ enables simultaneous cell typing and expressed variant detection within intact tissue sections. See how we used it to resolve mutation patterns and cell identity with spatial resolution in a single experiment. Cell identity, expressed variants, and spatial context in a single run Spatial biology has made remarkable progress over the last several years. Researchers can now profile gene expression across tissue sections with increasing resolution, map cell p
May 18, 2026
Read more →.jpeg)
Reading a cell’s history: How RETrace2 and AVITI™ are rewriting lineage tracing
Researchers at Altos Labs have developed a new way to reconstruct the developmental history of cells and high accuracy homopolymer sequencing on AVITI helped make it possible. Every cell carries a history Every cell accumulates a record of its lineage with a unique combination of somatic mutations. These molecular marks can reveal which cells are related and which diverged long before they took on a specialized identity.
Apr 23, 2026
Read more →
AGBT 2026 recap: Relentless innovation where it counts
AGBT is always one of the most exciting weeks of the year. It’s where the field gathers to share breakthroughs and get a first look at technologies that will shape the future of research.
Mar 12, 2026
Read more →.jpeg)
Beyond 2026: What we shared and what’s next
At our recent Beyond event, we shared our product roadmap updates across multiomics, spatial profiling, and high-throughput sequencing.
Feb 25, 2026
Read more →Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as employee counts and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.